94-5765. Opportunity for a License: Assay Using Recombinant Histidyl-tRNA Synthetase

[Federal Register Volume 59, Number 48 (Friday, March 11, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-5765]


[[Page Unknown]]

[Federal Register: March 11, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Opportunity for a License: Assay Using Recombinant Histidyl-tRNA 
Synthetase

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health desires to license (in 
accordance with 35 U.S.C. 207) a novel assay to detect auto-antibodies 
to histydyl tRNA synthetase, known as JO1. This diagnostic assay is 
able to detect the presence of various autoimmune diseases including 
myositis, polymyositis and dermatomyositis with more sensitivity than 
any diagnostic assay that is presently available. The antigen is highly 
stable on the ELISA plate at refrigerator temperatures for long periods 
of time.
    NIH is the assignee of the patent rights for this technology 
covered by U.S. Patent Application 08/052,404 and developed by Dr. Nina 
Raben and Dr. Paul Plotz of the National Institute of Arthritis and 
Musculoskeletal and Skin Diseases.

ADDRESSES: Licensing information and a copy of the U.S. patent 
application may be obtained by contacting Carol Lavrich, Technology 
Licensing Specialist, National Institutes of Health, Office of 
Technology Transfer, Box OTT, Bethesda, Maryland 20892 (telephone 301/
496-7735; fax [phone]). A signed confidentiality agreement will be 
required to receive copies of the patent application.

    Dated: February 25, 1994.
Donald P. Christoferson,
Acting Director, Office of Technology Transfer.
[FR Doc. 94-5765 Filed 3-10-94; 8:45 am]
BILLING CODE 4140-01-M